CARVEDILOL CONTROL in pharma franchise in Manipur

CARVEDILOL CONTROL in PCD pharma franchise in Shimla

CARVEDILOL CONTROL in top pharma company in Jaipur

CARVEDILOL CONTROL in pcd pharma supplier in Ajmer

CARVEDILOL CONTROL in phama franchise company in india
CARVEDILOL CONTROL phama distributor in Thane

Home/Products /carvedilol-control-release-20-mg-tablet

About the Product

Description


Cardistep CR 20 Tablet contains Carvedilol Controlled Release 20 mg, a beta-blocker primarily prescribed for the treatment of hypertension (high blood pressure), chronic heart failure, and angina (chest pain). This medication ensures a gradual and sustained release of the active ingredient, allowing for prolonged control of blood pressure and heart function with a once-daily dose.

Carvedilol works by blocking both beta-adrenergic and alpha-adrenergic receptors, resulting in lower heart rate, relaxed blood vessels, and improved blood circulation. By reducing the heart's workload, it effectively manages high blood pressure and prevents cardiovascular complications such as strokes, heart attacks, and kidney problems.

In patients suffering from chronic heart failure, Cardistep CR 20 helps enhance heart efficiency by strengthening the heart’s pumping ability, reducing symptoms like fatigue, shortness of breath, and swelling in the legs. It is also highly beneficial in post-heart attack recovery, preventing further cardiac deterioration.

For individuals with angina, this medication improves oxygen supply to the heart, reducing chest pain and preventing future cardiac events. By maintaining steady blood pressure levels, it reduces the risk of sudden fluctuations that can cause dizziness or fainting.

Cardistep CR 20 is formulated as a controlled-release tablet, ensuring that the drug is released gradually over time, leading to better treatment adherence and reduced risk of side effects associated with sudden drug level spikes. Patients should take it at the same time each day, preferably with food, to enhance its absorption and effectiveness. Abruptly stopping the medication is not recommended, as it can lead to serious complications, including a sudden increase in blood pressure or heart rate.

Common side effects may include dizziness, fatigue, low blood pressure, slow heart rate, nausea, and cold extremities.

Used to treat hypertension, chronic heart failure, and angina, improving overall heart function and reducing cardiovascular risks.

Do not discontinue use abruptly. Consult a doctor before changing the dose, especially if you have diabetes, asthma, or liver disorders.

Store in a cool, dry place, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Carvedilol Controlled Release 20 mg Tablet in the PCD pharma franchise market?

Carvedilol Controlled Release 20 mg Tablet has strong demand in the cardiology and hypertension segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.

Why should medical distributors include Carvedilol Controlled Release 20 mg Tablet in their product range?

Medical distributors and wholesalers can benefit from the consistent demand for controlled release beta-blockers like Carvedilol CR 20 mg Tablet in heart failure and blood pressure management. Including this product helps strengthen their cardiology and chronic care portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for Carvedilol Controlled Release 20 mg Tablet?

Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Carvedilol Controlled Release 20 mg Tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for Carvedilol Controlled Release 20 mg Tablet distribution?

Wholesalers and medical agencies benefit from attractive business margins, timely product availability, professional marketing support, and access to a trusted cardiology pharmaceutical range when partnering with Cafoli Lifecare for Carvedilol CR 20 mg Tablet distribution.

How can I become a distributor or franchise partner for Carvedilol Controlled Release 20 mg Tablet?

Medical distributors, stockists, wholesalers, and pharma professionals interested in Carvedilol Controlled Release 20 mg Tablet can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.